Literature DB >> 20720194

Osteoprotegerin: a biomarker with many faces.

Kenneth Caidahl, Thor Ueland, Pål Aukrust.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720194     DOI: 10.1161/ATVBAHA.110.208843

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  11 in total

1.  Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model.

Authors:  Peter M Grace; Daniel Hurley; Daniel T Barratt; Anna Tsykin; Linda R Watkins; Paul E Rolan; Mark R Hutchinson
Journal:  J Neurochem       Date:  2012-07-09       Impact factor: 5.372

2.  Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.

Authors:  Dorette Raaz-Schrauder; Michael G Schrauder; Christian Stumpf; Piotr Lewczuk; Tobias Kilian; Barbara Dietel; Christoph D Garlichs; Christian Schlundt; Stephan Achenbach; Lutz Klinghammer
Journal:  Heart Vessels       Date:  2017-05-31       Impact factor: 2.037

3.  Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease.

Authors:  Zi Ye; Zeenat Ali; George G Klee; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2013-01-11       Impact factor: 2.689

Review 4.  Osteoprotegerin in Cardiometabolic Disorders.

Authors:  C Pérez de Ciriza; A Lawrie; N Varo
Journal:  Int J Endocrinol       Date:  2015-05-11       Impact factor: 3.257

5.  Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice.

Authors:  Justyna Czapla; Sybilla Matuszczak; Ewa Wiśniewska; Magdalena Jarosz-Biej; Ryszard Smolarczyk; Tomasz Cichoń; Magdalena Głowala-Kosińska; Joanna Śliwka; Marcin Garbacz; Mateusz Szczypior; Tomasz Jaźwiec; Agnieszka Langrzyk; Michał Zembala; Stanisław Szala
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

6.  Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.

Authors:  Barbara Toffoli; Bruno Fabris; Giacomo Bartelloni; Fleur Bossi; Stella Bernardi
Journal:  Mediators Inflamm       Date:  2016-12-14       Impact factor: 4.711

7.  Distribution of alkaline phosphatase, osteopontin, RANK ligand and osteoprotegerin in calcified human carotid atheroma.

Authors:  Catherine L Higgins; Salim Isbilir; Pamela Basto; Iou Yih Chen; Muthiah Vaduganathan; Periyanan Vaduganathan; Michael J Reardon; Gerald Lawrie; Leif Peterson; Joel D Morrisett
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

8.  Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria.

Authors:  Niamh O'Regan; Chris Moxon; Kristina Gegenbauer; Jamie M O'Sullivan; Alain Chion; Owen P Smith; Roger J S Preston; Teresa M Brophy; Alister G Craig; James S O'Donnell
Journal:  Thromb Haemost       Date:  2016-01-14       Impact factor: 5.249

9.  Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease.

Authors:  Simona Mihai; Elena Codrici; Ionela Daniela Popescu; Ana-Maria Enciu; Elena Rusu; Diana Zilisteanu; Radu Albulescu; Gabriela Anton; Cristiana Tanase
Journal:  Dis Markers       Date:  2016-09-07       Impact factor: 3.434

10.  In Vivo siRNA Delivery Using JC Virus-like Particles Decreases the Expression of RANKL in Rats.

Authors:  Daniel B Hoffmann; Kai O Böker; Stefan Schneider; Ellen Eckermann-Felkl; Angelina Schuder; Marina Komrakova; Stephan Sehmisch; Jens Gruber
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-22       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.